These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38114011)

  • 1. Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2.
    Waqas M; Ullah S; Halim SA; Rehman NU; Ali A; Jan A; Muhsinah AB; Khan A; Al-Harrasi A
    Int J Biol Macromol; 2024 Feb; 258(Pt 1):128812. PubMed ID: 38114011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupting protease and deubiquitinase activities of SARS-CoV-2 papain-like protease by natural and synthetic products discovered through multiple computational and biochemical approaches.
    Waqas M; Ullah S; Ullah A; Halim SA; Rehman NU; Khalid A; Ali A; Khan A; Gibbons S; Csuk R; Al-Harrasi A
    Int J Biol Macromol; 2024 Oct; 277(Pt 4):134476. PubMed ID: 39111477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches.
    Bhowmick S; Saha A; AlFaris NA; ALTamimi JZ; ALOthman ZA; Aldayel TS; Wabaidur SM; Islam MA
    J Mol Graph Model; 2022 Mar; 111():108113. PubMed ID: 34959151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2.
    Singh E; Jha RK; Khan RJ; Kumar A; Jain M; Muthukumaran J; Singh AK
    Comput Biol Chem; 2022 Aug; 99():107721. PubMed ID: 35835027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining computational and experimental evidence on the activity of antimalarial drugs on papain-like protease of SARS-CoV-2: A repurposing study.
    Ribaudo G; Yun X; Ongaro A; Oselladore E; Ng JPL; Haynes RK; Law BYK; Memo M; Wong VKW; Coghi P; Gianoncelli A
    Chem Biol Drug Des; 2023 Apr; 101(4):809-818. PubMed ID: 36453012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial based natural compounds as potential inhibitors for SARS-CoV-2 Papain-like protease (PLpro): a molecular docking and dynamic simulation study.
    Rahul S; Sarkar A
    J Biomol Struct Dyn; 2022; 40(24):13848-13858. PubMed ID: 34730069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of aurintricarboxylic acid as a potential inhibitor of SARS-CoV-2 PLpro.
    Arya R; Prashar V; Kumar M
    Int J Biol Macromol; 2023 Mar; 230():123347. PubMed ID: 36682650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease.
    Srinivasan V; Brognaro H; Prabhu PR; de Souza EE; Günther S; Reinke PYA; Lane TJ; Ginn H; Han H; Ewert W; Sprenger J; Koua FHM; Falke S; Werner N; Andaleeb H; Ullah N; Franca BA; Wang M; Barra ALC; Perbandt M; Schwinzer M; Schmidt C; Brings L; Lorenzen K; Schubert R; Machado RRG; Candido ED; Oliveira DBL; Durigon EL; Niebling S; Garcia AS; Yefanov O; Lieske J; Gelisio L; Domaracky M; Middendorf P; Groessler M; Trost F; Galchenkova M; Mashhour AR; Saouane S; Hakanpää J; Wolf M; Alai MG; Turk D; Pearson AR; Chapman HN; Hinrichs W; Wrenger C; Meents A; Betzel C
    Commun Biol; 2022 Aug; 5(1):805. PubMed ID: 35953531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19.
    Hersi F; Sebastian A; Tarazi H; Srinivasulu V; Mostafa A; Allayeh AK; Zeng C; Hachim IY; Liu SL; Abu-Yousef IA; Majdalawieh AF; Zaher DM; Omar HA; Al-Tel TH
    Eur J Med Chem; 2023 Jun; 254():115380. PubMed ID: 37075625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of Deubiquitinating Enzymes Interfere with the SARS-CoV-2 Papain-like Protease and Block Virus Replication In Vitro.
    Große M; Setz C; Rauch P; Auth J; Morokutti-Kurz M; Temchura V; Schubert U
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease.
    Zou Z; Shan H; Sun D; Xia L; Shi Y; Wan J; Zhou A; Wu Y; Xu H; Lei H; Xu Z; Wu Y
    Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(8):1133-1139. PubMed ID: 35866602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising antivirals for PLpro of SARS-CoV-2 using virtual screening, molecular docking, dynamics, and MMPBSA.
    Kumari R; Kumar V; Dhankhar P; Dalal V
    J Biomol Struct Dyn; 2023 Jul; 41(10):4650-4666. PubMed ID: 35510600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site.
    van Vliet VJE; Huynh N; Palà J; Patel A; Singer A; Slater C; Chung J; van Huizen M; Teyra J; Miersch S; Luu GK; Ye W; Sharma N; Ganaie SS; Russell R; Chen C; Maynard M; Amarasinghe GK; Mark BL; Kikkert M; Sidhu SS
    PLoS Pathog; 2022 Dec; 18(12):e1011065. PubMed ID: 36548304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.
    Lindner HA; Fotouhi-Ardakani N; Lytvyn V; Lachance P; Sulea T; Ménard R
    J Virol; 2005 Dec; 79(24):15199-208. PubMed ID: 16306591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chalcone-amide, a privileged backbone for the design and development of selective SARS-CoV/SARS-CoV-2 papain-like protease inhibitors.
    Valipour M
    Eur J Med Chem; 2022 Oct; 240():114572. PubMed ID: 35797899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new non-covalent and covalent inhibitors targeting SARS-CoV-2 papain-like protease and main protease.
    Liu W; Wang J; Wang S; Yue K; Hu Y; Liu X; Wang L; Wan S; Xu X
    Bioorg Chem; 2023 Nov; 140():106830. PubMed ID: 37683544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease.
    Patchett S; Lv Z; Rut W; Békés M; Drag M; Olsen SK; Huang TT
    Cell Rep; 2021 Sep; 36(13):109754. PubMed ID: 34547223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations.
    Holmes J; Islam SM; Milligan KA
    Viruses; 2024 May; 16(6):. PubMed ID: 38932170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
    Balkrishna A; Mittal R; Arya V
    Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the Ubiquitin and ISG15 Deconjugase Activity of SARS-CoV-1 and SARS-CoV-2 Papain-Like Protease.
    Nayak D; Dos Santos Bury P; Drag M; Nijkerk AN; El Oualid F; Olsen SK
    Methods Mol Biol; 2023; 2591():171-188. PubMed ID: 36350549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.